Clinical Trials on Advanced Cancer in Hong Kong
Total 1058 results
-
PROCEPT BioRoboticsRecruitingBenign Prostatic Hyperplasia | Localized Prostate CancerLebanon, Hong Kong, United States
-
Novartis PharmaceuticalsCompletedAdvanced Triple Negative Breast Cancer (TNBC) With High TAMsFrance, Italy, Austria, Taiwan, United States, Spain, Australia, Korea, Republic of, Belgium, Germany, Hong Kong, Turkey
-
Matrix PharmaceuticalUnknown
-
GlaxoSmithKlineCompletedCancerKorea, Republic of, Hong Kong, Pakistan, Singapore
-
Novartis PharmaceuticalsTerminatedAdvanced Hepatocellular Carcinoma With c-MET DysregulationChina, Hong Kong, Thailand, Singapore
-
Chinese University of Hong KongChangi General Hospital; Kosin University Gospel Hospital; Shizuoka Cancer Center and other collaboratorsCompletedEarly Gastric Cancer | Gastric NeoplasmJapan, Singapore, Korea, Republic of, Hong Kong
-
BayerNo longer availableCancerBrazil, Hong Kong, Hungary, Malaysia, Poland, Romania, Russian Federation, Taiwan, Ukraine, Ireland, Chile
-
Servier Bio-Innovation LLCRegeneron Pharmaceuticals; Institut de Recherches Internationales ServierNot yet recruitingNon-small Cell Lung Cancer (NSCLC)Hong Kong, United States, Australia
-
University of WashingtonNational Cancer Institute (NCI); National Institutes of Health (NIH)TerminatedCervical Adenocarcinoma | Cervical Adenosquamous Carcinoma | Cervical Squamous Cell Carcinoma, Not Otherwise Specified | Recurrent Cervical Carcinoma | Cervical Undifferentiated Carcinoma | Stage IIA Cervical Cancer | Stage IIB Cervical Cancer | Stage III Cervical Cancer | Stage IVA Cervical Cancer | Stage... and other conditionsUnited States, Hong Kong, Canada
-
Harbour BioMed US, Inc.CompletedAdvanced Solid TumorAustralia, China, Hong Kong
-
Hoffmann-La RocheCompletedNasopharyngeal CancerHong Kong, Thailand, Indonesia, Taiwan, Malaysia
-
Novartis PharmaceuticalsWithdrawnAdvanced Hepatocellular CarcinomaGermany, Australia, Hong Kong, Switzerland, Spain, France, United States
-
AstraZenecaIonis Pharmaceuticals, Inc.CompletedAdvanced Adult Hepatocellular Carcinoma | Hepatocellular Carcinoma MetastaticKorea, Republic of, Taiwan, Hong Kong, Japan
-
Cancer Therapeutics Research GroupNational Cancer Institute (NCI)CompletedProstate CancerAustralia, Singapore, Hong Kong
-
Cancer Therapeutics Research GroupNational Cancer Institute (NCI)CompletedGastric CancerAustralia, Singapore, Hong Kong, Korea, Republic of
-
Progen PharmaceuticalsTerminatedCancer | Hepatocellular Carcinoma | Primary Liver Cancer | Liver Cancer | HepatomaHong Kong, Singapore, United States, Australia, Canada, Italy, Malaysia, Spain, Taiwan, Thailand
-
Novartis PharmaceuticalsCompletedHormone Receptor Positive, HER2-negative, Advanced Breast CancerJapan, Hong Kong, Singapore
-
National Cancer Centre, SingaporeSingapore General HospitalRecruitingNon-Small Cell Lung Cancer | Lung CancerThailand, Singapore, Hong Kong, Brunei Darussalam, India, Malaysia
-
National Cancer Centre, SingaporePfizerActive, not recruitingNSCLC Stage IV | NSCLC Stage IIIB | Recurrent NSCLC | NSCLC Stage IIIC | EGFR Positive Non-Small Cell Lung CancerKorea, Republic of, Hong Kong, Thailand, Singapore, Malaysia
-
Boston PharmaceuticalsCompletedAdvanced Nonhaematologic MalignanciesUnited States, Korea, Republic of, Taiwan, France, Hong Kong, Belgium, Spain
-
Cullinan Oncology, LLCNational Cancer Institute (NCI)TerminatedNasopharyngeal Carcinoma | Nasopharyngeal CancerFrance, Singapore, United States, China, Hong Kong
-
National Medical Research Council (NMRC), SingaporeCompletedLiver CancerNew Zealand, Hong Kong, Indonesia, Malaysia, Pakistan, Singapore
-
Puma Biotechnology, Inc.CompletedBreast Neoplasms | Advanced Breast Cancer | Advanced Malignant Solid TumorsUnited States, Belgium, China, Hong Kong, Canada, Korea, Republic of, India, Poland, Ukraine
-
Cancer Therapeutics Research GroupNational Cancer Institute (NCI)CompletedLung CancerAustralia, Singapore, Hong Kong, Korea, Republic of
-
Treadwell Therapeutics, IncTIO Discovery EngineRecruitingAdvanced Solid MalignanciesUnited States, Hong Kong, Canada
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerHong Kong, Korea, Republic of, Taiwan, Thailand
-
Broncus Medical IncCompletedLung CancerUnited States, China, Germany, Hong Kong
-
BinexUnknown
-
Shenzhen People's HospitalSixth Affiliated Hospital, Sun Yat-sen University; The University of Hong Kong-Shenzhen...RecruitingLocally Advanced Rectal CarcinomaChina
-
Novartis PharmaceuticalsActive, not recruitingEGFR-mutant Non-small Cell Lung CancerTaiwan, Germany, Canada, Italy, Singapore, Hong Kong
-
BinexUnknownAdvanced Colorectal CancerKorea, Republic of
-
National Cancer Institute (NCI)CompletedRecurrent Bladder Cancer | Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter | Stage IV Bladder Cancer | Transitional Cell Carcinoma of the Bladder | Distal Urethral Cancer | Proximal Urethral Cancer | Recurrent Urethral Cancer | Urethral Cancer Associated With Invasive Bladder CancerUnited States, China, Korea, Republic of
-
National Hospital Organization Nagoya Medical CenterRecruitingAcute Lymphoblastic Leukemia | Down Syndrome | Childhood CancerTaiwan, Thailand, Hong Kong, Singapore, Malaysia, Japan
-
Uppsala UniversityBaylor College of Medicine; Sahlgrenska University Hospital, Sweden; University... and other collaboratorsRecruitingBreast Cancer | Breast Neoplasms | Sentinel Lymph Node | DCISUnited States, Sweden, Hong Kong
-
PfizerTerminatedBreast CancerUnited States, Belgium, Hungary, China, Hong Kong, Poland, Singapore
-
PfizerTerminatedAdvanced Breast CancerUnited States, Hungary, Spain, Belgium, China, Hong Kong, Australia, Poland, Canada, India, South Africa
-
Hoffmann-La RocheCompletedCarcinoma, Hepatocellular | Liver Metastases | Biliary Tract Cancer | Secondary Liver CancerKorea, Republic of, Denmark, Spain, Taiwan, United States, Hong Kong
-
ASLAN PharmaceuticalsCompletedMetastatic Breast CancerAustralia, Hong Kong, Korea, Republic of, New Zealand, Philippines, Singapore, Taiwan
-
Yiviva Inc.RecruitingAdvanced Hepatocellular CarcinomaUnited States, Taiwan, China, Hong Kong
-
Zai Lab (Shanghai) Co., Ltd.TerminatedGastric Cancer | Triple Negative Breast Cancer | Endometrial Carcinoma | Biliary Tract CarcinomaChina
-
Eli Lilly and CompanyCompletedNon Small Cell Lung CancerTaiwan, Korea, Republic of, Singapore, Thailand, Hong Kong
-
Smith & Nephew, Inc.RecruitingAdvanced Degeneration of the Hip Joint | Revision of the Hip JointUnited States, Canada, Australia, Hong Kong, India
-
Cellxpert Biotechnology Corp.Medigen Biotechnology CorporationTerminatedCancer | Hepatocellular Carcinoma | Liver CancerKorea, Republic of, Taiwan, Hong Kong, China
-
Taiho Pharmaceutical Co., Ltd.TerminatedHead and Neck CancerUnited States, Hong Kong, Singapore, Taiwan
-
Puma Biotechnology, Inc.CompletedBreast CancerSpain, United Kingdom, France, United States, Denmark, Hong Kong
-
Novartis PharmaceuticalsCompletedMelanoma | CancerTaiwan, Thailand, China, Hong Kong, Korea, Republic of
-
Novartis PharmaceuticalsActive, not recruitingMelanoma | Carcinoma, Non-Small-Cell Lung | Nasopharyngeal Carcinoma | Triple Negative Breast Cancer | Microsatellite Stable Colorectal CancerUnited States, Taiwan, Spain, Germany, Japan, Hong Kong
-
Hoffmann-La RocheCompletedNon-Small Cell Lung CancerHong Kong, Taiwan, Philippines, China, Thailand, Indonesia, Australia, Korea, Republic of
-
Puma Biotechnology, Inc.CompletedBreast Cancer | Advanced Malignant Solid TumorsUnited States, Taiwan, United Kingdom, Hong Kong, Belgium, France, Spain, China, Netherlands, Poland, Sweden
-
Eli Lilly and CompanyCompletedAdvanced CancerPuerto Rico, United States